ALMAG -01 portable magnetotherapy device is intended to be used for various diseases physiotherapeutic treatment and prevention with a help of travelling pulsed magnetic field both in patient care and prophylactic institutions and at home conditions for patient self-application.

Almag-01 - portable magnetotherapy device with a travelling pulsed magnetic field (TPMF) for use in home condition.

Locomotor System Diseases

  • Spinal osteochondrosis with reflex cervical spine, thorax and loin radicular syndrome
  • Deforming osteoarthrosis
  • arthritis and arthrosis of different joints: scapulohumeral periarthrosis, arthritis, epicondylitis, gout
  • bursitis
  • myositis
  • parantnoit

Locomotor System Injuries and their after-effects

  • Bone Fractures
  • internal joint damages
  • posttraumatic joint contracture
  • wound, soft tissue bruise, hematoma, posttraumatic edema
  • muscle and ligaments injuries
  • postoperative wounds
  • keloid cicatrix
  • sluggish purulent wounds, phlegmons, burns

Neurologic Diseases

  • Diseases of peripheral nervous system
  • neuritises
  • facial nerve neuritis
  • radial nerve neuritis
  • ulnar nerve neuritis
  • median nerve neuritis
  • sciatic nerve (ischias) neuritis
  • peroneal nerve neuritis
  • plexitis
  • neuralgias
  • trigeminal nerve neuralgia
  • occipital nerve neuralgia
  • intercostal neuralgia

Traumas of Central Nervous System

  • trauma of a backbone and a spinal cord
  • disorder of a spinal blood circulation
  • circulation with chronic ischemic illness of heart

Brain vascular diseases

  • ischemic cerebral stroke

Diseases of Cardiovascular System

  • idiopathic hypertensia of I - II degree
  • renal hypertonia
  • vegetovascular dystonia on hypertonic type
  • ischemic illness of heart with a stable stenocardia (under the medial supervision)
  • obliterating atherosclerosis of vessels of the lower extremities (obliterating endarteritis)

Diabetes Mellitus Complications

  • diabetic angiopathy
  • diabetic polyneuropathy

Dermatologic Diseases

  • itching dermatosis
  • dermal plastic operation postoperative condition

Chronic nonspecific lung diseases

  • chronic bronchitis
  • chronic pneumonia
  • bronchial asthma

Gastrointestinal tract disorders

  • subacute and chronic pancreatitis
  • biliary dyskinesia
  • chronic gastritis
  • stomach and duodenum ulcer

Female genital organs diseases

  • uterus and uterine appendages inflammatory diseases in the subacute period
  • diseases caused by ovary hypofunction
  • cesarean post operation condition

Venous disorders of upper and lower extremities

  • thrombosis of deep crus veins
  • chronic thrombophlebitis at the trophic disturbance stage
  • varicose disease
  • inflammatory diseases in the acute phase
  • hemorrhage and predisposition to it
  • high-grade hypotension
  • purulent processes before surgical treatment
  • severe cardiac ischemia;
  • early post infarction period
  • acute phase of cerebral blood circulation disturbance (stroke)
  • pregnancy
  • systemic blood diseases
  • oncological diseases
  • thyrotoxicosis
  • diencephalic syndrome
  • the presence of implanted cardiostimulator in the zone of action Small metal inclusions in the bone tissueare not contraindications for the device application in the therapeutic doses

Physiological effect of traveling pulsed magnetic field on human organizm

Action of magnetic field on an organism is characterized by:

The cumulative scientific material testifies that in a basis of a medical effect of magnetic fields is their ability both to control the flow of the charged particles and to make action on the magnetised bodies irrespective of a condition of their flow. As a result you can have a positive effect upon natural biological process resulting in intensifying of intracellular and intercellular metabolism. Thus magnetic field therapy is undeniably promotes the body`s own restorative function in the healing process by direct stimulation– without surgical intervention, without drugs, without side effect. Medical effect of magnetic field as compared both with static and alternating magnetic fields is mostly

expressed in travelling pulsed magnetic field of ALMAG device. The travelling pulsedmagnetic field of ALMAG, with the frequency of impulses coinciding with those of the biological active frequency of the person organism( from 4 to 16 Hz) is able to achieve the best therapeutic effect as compared to that of constant and variable magnetic field. The unique design of ALMAG induction coils allows travelling impulsive magnetic field to penetrate deep into tissues of the patient to 8 cm, that is successfully applied for the treatment of diseases of the internal organs. The influence of strictly rhythmical travelling impulsive magnetic field produced by the device on the diseased organs of the human body makes a positive effect on your body finally stimulating dysfunction recovery.

Besides, under the influence of a magnetic field in a place of the device positioning there is the improvement of blood flow and oxygen supply leading to the reduction both of blood viscosity and accordingly the risk of formation of thromboses. The vessels lumen is enlarged, additional capillaries are opened and their permeability are improved. All these result in increase of blood supply in the affected area; cells Oxygenium, immunoglobulins, building proteins provision; increase of capillary blood flow, improve of capillary tone and contractility as well as increase of capillary blood filling; moving of inflammation products out. The activation of metabolism prevents the disease worsen progressively grow, increases the process of regeneration and metabolic activity, recovery and of the diseased cells. The application of low-frequency travelling pulsed magnetic fields to treat patients with different pathologies has a number of beneficial effects on your body :

  • stimulation the processes of nervous inhibition responsible for a sedative effect followed by emotional stress relief and sleep normalisation
  • cerebral vascular tone release, improvement of cerebral blood circulation, activation of nitrogenous and carbohydrate-phosphoric metabolism increases cerebral hypoxia resistance
  • systolic and diastolic pressure decrease down to normal values
  • analgesic effect due to sensitivity reduction of peripheral nervous receptors
  • training response and activity improvement of all endocrine systems
  • increase of vascular and epithelial permeability which leads to accelerated resolution of edema and introduced medicinal agents
  • metabolism improvement followed by attenuation of pathologic processes in the liver, heart and other organs
  • increase of body resistance to unfavourable effects
  • Mains circuit voltage ~220V (-10%; +10%) or ~230V (-10%;+6%), frequency 50Hz
  • Power consumption: not more than 15 VA
  • Weight: max. 0,62 kg
  • Overall dimensions of: electronic unit 137x60x44 mm one of the coils of exposure assembly - 15xǾ90 mm Note: extreme deviations: ±3%
  • The number of exposing coils-inductors - 4
  • Amplitude value of magnetic induction on the functional surface (both flat surface) of the device exposure assembly coil-indictor: (20±6) mTl
  • Pulse duration: 1,5 - 2,5 ms. Magnetic field pulse repetition frequency per coil: 6 Hz. 2.8 The device activation, its connection to the mains, is followed with LED light indication
  • The device provides recurring-short-term operating mode within 6 hours: operation (action) period - (22±1) min., break - 10 min
  • Device is automatically disconnected from the electric mains after (22±1) min. operation
  • Environmental resistance of the Device is the type of moderate cold climate design apparatus
  • OThe outer surfaces of the device are resistant to disinfection by chamical method: 3% solution of hydrogen peroxide with 0,5% detergent of “Lotos” type or 1% solution of chloramine
  • Mean-time-between-failure: min. 1000 h
  • Mean service life - five years
  • The Device is made of the material which produces no irritating or allergic effect
  • Maximum temperature after one operation cycle: - device case, max. - 45 °C; - device exposure assembly unit , max. – 41 °C
  • Class of the device depending on potential risk of application - 2а